Literature DB >> 2958659

Elevation of serum beta-hexosaminidase and alpha-D-mannosidase in type 2 Gaucher disease: a clinical and biochemical study.

D Chitayat1, S Nakagawa, R W Marion, G S Sachs, S Shinnar, J F Llena, H M Nitowsky.   

Abstract

We report a case of a black infant who died at 9 months of age with clinical and pathological findings consistent with the acute neuronopathic form of Gaucher disease (Type 2). Analysis of peripheral blood platelets obtained from this child demonstrated very low levels of beta-glucosidase activity. beta-hexosaminidase (HEX) activity in the serum, however, was 30 times greater than the level in control sera and 15 times greater than the level observed in individuals affected with the chronic form of Gaucher disease (Type 1). Similarly, alpha-D-mannosidase (MANN) activity in the proband's serum was significantly elevated when compared with controls, and chronic Gaucher disease patients. We postulate that the cause of the elevation of these lysosomal enzymes is similar to the cause of elevation in Type 1 individuals but that patients with Type 2 Gaucher disease have a more serious cellular defect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958659     DOI: 10.1007/bf01800033

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  7 in total

1.  Characterization of lysosomal hydrolases that are elevated in Gaucher's disease.

Authors:  K D Moffitt; J P Chambers; W F Diven; R H Glew; D A Wenger; D F Farrell
Journal:  Arch Biochem Biophys       Date:  1978-09       Impact factor: 4.013

2.  Phosphatase studies in Gaucher's disease.

Authors:  A C CROCKER; B H LANDING
Journal:  Metabolism       Date:  1960-04       Impact factor: 8.694

3.  The multiple forms of alpha-D-mannosidase in human plasma.

Authors:  S Hirani; B Winchester
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

4.  Changes of serum hexosaminidase for the presumptive diagnosis of type I Gaucher disease in Tay-Sachs carrier screening.

Authors:  S Nakagawa; S Kumin; G Sachs; H M Nitowsky
Journal:  Am J Med Genet       Date:  1983-03

5.  Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.

Authors:  I Gery; J S Zigler; R O Brady; J A Barranger
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  Heterozygote detection of type I Gaucher disease using blood platelets.

Authors:  S Nakagawa; S Kumin; G Sachs; H M Nitowsky
Journal:  Clin Chim Acta       Date:  1982-01-05       Impact factor: 3.786

7.  Human hexosaminidase isozymes: chromatographic separation as an aid to heterozygote identification.

Authors:  S Nakagawa; S Kumin; H M Nitowsky
Journal:  Clin Chim Acta       Date:  1977-03-01       Impact factor: 3.786

  7 in total
  2 in total

Review 1.  Are there useful biochemical markers of disease activity in lysosomal storage diseases?

Authors:  B Winchester
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Highly increased levels of serum beta-hexosaminidase, arylsulphatase A and beta-galactosidase in a patient with sepsis.

Authors:  T Tønnesen; P Andersen; F Güttler
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.